Ausgabe 7/2019
Inhalt (23 Artikel)
Up front
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Nathalie Esser, Sakeneh Zraika
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
Helen R. Murphy
Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis
Jakob Tarp, Andreas P. Støle, Kim Blond, Anders Grøntved
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
Karl Kristensen, Linda E. Ögge, Verena Sengpiel, Karin Kjölhede, Annika Dotevall, Anders Elfvin, Filip K. Knop, Nana Wiberg, Anastasia Katsarou, Nael Shaat, Lars Kristensen, Kerstin Berntorp
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo J. L. Heerspink, Paul Perco, Skander Mulder, Johannes Leierer, Michael K. Hansen, Andreas Heinzel, Gert Mayer
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
Nicholas J. Thomas, Anita L. Lynam, Anita V. Hill, Michael N. Weedon, Beverley M. Shields, Richard A. Oram, Timothy J. McDonald, Andrew T. Hattersley, Angus G. Jones
Perinatal risk factors for type 1 diabetes revisited: a population-based register study
Ingeborg Waernbaum, Gisela Dahlquist, Torbjörn Lind
Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017
Donghee Kim, Andrew A. Li, George Cholankeril, Sun H. Kim, Erik Ingelsson, Joshua W. Knowles, Robert A. Harrington, Aijaz Ahmed
The impact of diabetes on productivity in China
Thomas R. Hird, Ella Zomer, Alice Owen, Lei Chen, Zanfina Ademi, Dianna J. Magliano, Danny Liew
Genome-wide association study of type 2 diabetes in Africa
Ji Chen, Meng Sun, Adebowale Adeyemo, Fraser Pirie, Tommy Carstensen, Cristina Pomilla, Ayo P. Doumatey, Guanjie Chen, Elizabeth H. Young, Manjinder Sandhu, Andrew P. Morris, Inês Barroso, Mark I. McCarthy, Anubha Mahajan, Eleanor Wheeler, Charles N. Rotimi, Ayesha A. Motala
Glucose controls glucagon secretion by directly modulating cAMP in alpha cells
Qian Yu, Hongyan Shuai, Parvin Ahooghalandari, Erik Gylfe, Anders Tengholm
Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice
Atsushi Obata, Tomohiko Kimura, Yoshiyuki Obata, Masashi Shimoda, Tomoe Kinoshita, Kenji Kohara, Seizo Okauchi, Hidenori Hirukawa, Shinji Kamei, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice
Midhat H. Abdulreda, R. Damaris Molano, Gaetano Faleo, Maite Lopez-Cabezas, Alexander Shishido, Ulisse Ulissi, Carmen Fotino, Luis F. Hernandez, Ashley Tschiggfrie, Virginia R. Aldrich, Alejandro Tamayo-Garcia, Allison S. Bayer, Camillo Ricordi, Alejandro Caicedo, Peter Buchwald, Antonello Pileggi, Per-Olof Berggren
Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes
Lars C. Gormsen, Esben Søndergaard, Nana L. Christensen, Kim Brøsen, Niels Jessen, Søren Nielsen
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
Shelley J. Edmunds, Rebeca Liébana-García, Oktawia Nilsson, Joan Domingo-Espín, Caitriona Grönberg, Karin G. Stenkula, Jens O. Lagerstedt
Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes
Jenny M. Wadén, Emma H. Dahlström, Nina Elonen, Lena M. Thorn, Johan Wadén, Niina Sandholm, Carol Forsblom, Per-Henrik Groop
Bone marrow pericyte dysfunction in individuals with type 2 diabetes
Giuseppe Mangialardi, David Ferland-McCollough, Davide Maselli, Marianna Santopaolo, Andrea Cordaro, Gaia Spinetti, Maria Sambataro, Niall Sullivan, Ashley Blom, Paolo Madeddu
Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor
Vit Neuman, Ondrej Cinek, David P. Funda, Tomas Hudcovic, Jaroslav Golias, Lenka Kramna, Lenka Petruzelkova, Stepanka Pruhova, Zdenek Sumnik
Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia
Zexu Dang, Elisa Avolio, Ambra Albertario, Graciela B. Sala-Newby, Anita C. Thomas, Nianhong Wang, Costanza Emanueli, Paolo Madeddu
The Integrated Islet Distribution Program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles
Marcela Brissova, Joyce C. Niland, James Cravens, Barbara Olack, Janice Sowinski, Carmella Evans-Molina
Correction to: Bone marrow pericyte dysfunction in individuals with type 2 diabetes
Giuseppe Mangialardi, David Ferland-McCollough, Davide Maselli, Marianna Santopaolo, Andrea Cordaro, Gaia Spinetti, Maria Sambataro, Niall Sullivan, Ashley Blom, Paolo Madeddu